COMP <GO>
NRC vs BIAF // GROSS PROFIT MARGIN
NRC Health (NASDAQ) VS. bioAffinity Technologies Inc. (NASDAQ) • 15-METRIC TALLY: NRC 8
— BIAF 0
■ METRIC PARITY
LAST: $23.49 (+0.09%) • MKT CAP: $519.6M
gross-margins
—
LAST: $3.03 (-3.50%) • MKT CAP: $3.9M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. BIAF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NRC | BIAF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.00% | -35.00% | +56.00 | NRC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.03% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 16.40% | -60.00% | +76.40 | NRC | /operating-margins <GO> |
| Net Profit Margin | 8.40% | -60.00% | +68.40 | NRC | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | -34.20% | +30.20 | NRC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.11% | 0.00% | +2.11 | NRC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.82 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | NRC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.7 | 34.0 | +32.68 | NRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $519.6M | $3.9M | $515.7M | NRC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NRC REV | BIAF REV | NRC GROSS % | BIAF GROSS % | NRC FCF | BIAF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $137.4M | $6.2M | — | — | $15.7M | -$9.4M |
| FY 2024 | $143.1M | $9.4M | — | — | $19.2M | -$7.3M |
| FY 2023 | $148.6M | $2.5M | — | — | $38.1M | -$6.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
BIAF // BETA —